C M Proby
Overview
Explore the profile of C M Proby including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
74
Citations
970
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kwiatkowska M, Ahmed S, Ardern-Jones M, Bhatti L, Bleiker T, Gavin A, et al.
Skin Health Dis
. 2022 Jun;
1(4):e61.
PMID: 35663774
Introduction: The most common cancers in the UK are keratinocyte cancers (KCs): the combined term for basal cell carcinomas (BCCs) and cutaneous squamous cell carcinomas (cSCCs). Registration of KC is...
2.
Kwiatkowska M, Ahmed S, Ardern-Jones M, Bhatti L, Bleiker T, Gavin A, et al.
Br J Dermatol
. 2021 Sep;
186(2):367-369.
PMID: 34564854
No abstract available.
3.
Venables Z, Ahmed S, Bleiker T, Broggio J, Kwiatkowska M, Levell N, et al.
Br J Dermatol
. 2021 May;
185(2):460-462.
PMID: 33937975
No abstract available.
4.
Butt S, Chin K, Proby C, Affleck A
Clin Exp Dermatol
. 2020 Dec;
46(4):743-744.
PMID: 33368474
No abstract available.
5.
Durack A, Gran S, Gardiner M, Jain A, Craythorne E, Proby C, et al.
Br J Dermatol
. 2020 Jun;
184(4):731-739.
PMID: 32599647
Background: Dermatofibrosarcoma protuberans (DFSP) is a rare skin cancer. Standard treatment in the UK is either wide local excision (WLE) or Mohs micrographic surgery (MMS). It is unclear which approach...
6.
Gollins C, Shah A, Sinha K, Khan S, Paul N, Meeajun B, et al.
Br J Dermatol
. 2020 Mar;
183(2):394-396.
PMID: 32119116
No abstract available.
7.
8.
Jackson D, Hogarth F, Sutherland D, Holmes E, Donnan P, Proby C
Br J Dermatol
. 2020 Feb;
183(2):222-230.
PMID: 32030723
Background: Actinic keratosis (AK) is a common premalignant skin lesion that can progress to cutaneous squamous cell carcinoma (cSCC). Microwave therapy is an established cancer treatment and has been used...
9.
Willenbrink T, Jambusaria-Pahlajani A, Arron S, Seckin D, Harwood C, Proby C
J Eur Acad Dermatol Venereol
. 2019 Dec;
33 Suppl 8:57-60.
PMID: 31833603
Immunosuppression, both iatrogenic and disease-related, is associated with a greatly increased incidence of cutaneous SCC (cSCC) and with aggressive cSCC and worse disease outcomes. Consequently, rapid access to skin cancer...
10.
Leigh I, Proby C, Inman G, Harwood C
Br J Dermatol
. 2019 Apr;
180(5):961-963.
PMID: 31025740
No abstract available.